Your browser doesn't support javascript.
loading
Morpholino-based correction of hypomorphic ZAP70 mutation in an adult with combined immunodeficiency.
Gavino, Christina; Landekic, Marija; Zeng, Jibin; Wu, Ning; Jung, Sungmi; Zhong, Ming-Chao; Cohen-Blanchet, Alexis; Langelier, Mélanie; Neyret, Odile; Lejtenyi, Duncan; Rochefort, Claudia; Cotton-Montpetit, Judith; McCusker, Christine; Mazer, Bruce; Veillette, André; Vinh, Donald C.
Afiliação
  • Gavino C; Infectious Disease Susceptibility Program, McGill University Health Centre (MUHC) and Research Institute-MUHC (RI-MUHC), Montreal, Quebec, Canada.
  • Landekic M; Infectious Disease Susceptibility Program, McGill University Health Centre (MUHC) and Research Institute-MUHC (RI-MUHC), Montreal, Quebec, Canada.
  • Zeng J; Infectious Disease Susceptibility Program, McGill University Health Centre (MUHC) and Research Institute-MUHC (RI-MUHC), Montreal, Quebec, Canada.
  • Wu N; Laboratory of Molecular Oncology, Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
  • Jung S; Department of Pathology, MUHC, Montreal, Quebec, Canada.
  • Zhong MC; Laboratory of Molecular Oncology, Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
  • Cohen-Blanchet A; Bioinformatics & Molecular Biology Core Facility, IRCM, Montreal, Quebec, Canada.
  • Langelier M; Infectious Disease Susceptibility Program, McGill University Health Centre (MUHC) and Research Institute-MUHC (RI-MUHC), Montreal, Quebec, Canada.
  • Neyret O; Bioinformatics & Molecular Biology Core Facility, IRCM, Montreal, Quebec, Canada.
  • Lejtenyi D; Department of Pediatrics, Division of Allergy & Clinical Immunology, MUHC, Montreal, Quebec, Canada.
  • Rochefort C; Infectious Disease Susceptibility Program, McGill University Health Centre (MUHC) and Research Institute-MUHC (RI-MUHC), Montreal, Quebec, Canada.
  • Cotton-Montpetit J; Bioinformatics & Molecular Biology Core Facility, IRCM, Montreal, Quebec, Canada.
  • McCusker C; Department of Pediatrics, Division of Allergy & Clinical Immunology, MUHC, Montreal, Quebec, Canada.
  • Mazer B; Department of Pediatrics, Division of Allergy & Clinical Immunology, MUHC, Montreal, Quebec, Canada.
  • Veillette A; Laboratory of Molecular Oncology, Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada.
  • Vinh DC; Infectious Disease Susceptibility Program, McGill University Health Centre (MUHC) and Research Institute-MUHC (RI-MUHC), Montreal, Quebec, Canada; Laboratory of Molecular Oncology, Institut de recherches cliniques de Montréal (IRCM), Montreal, Quebec, Canada. Electronic address: donald.vinh@mcgill.c
J Allergy Clin Immunol ; 139(5): 1688-1692.e10, 2017 05.
Article em En | MEDLINE | ID: mdl-28216435
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Terapia Genética / Imunodeficiência Combinada Severa / Proteína-Tirosina Quinase ZAP-70 / Morfolinos / Mutação Limite: Adult / Humans / Male País/Região como assunto: Africa Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfócitos T / Terapia Genética / Imunodeficiência Combinada Severa / Proteína-Tirosina Quinase ZAP-70 / Morfolinos / Mutação Limite: Adult / Humans / Male País/Região como assunto: Africa Idioma: En Revista: J Allergy Clin Immunol Ano de publicação: 2017 Tipo de documento: Article